Plozalizumab, CAS [[1610761-46-0]] Preis auf Anfrage

Produktübersicht

• Artikelname: Plozalizumab, CAS [[1610761-46-0]] Preis auf Anfrage
• Artikelnummer: MCE-HY-P99781
• Hersteller Artikelnummer: HY-P99781
• Alternativnummer: MCE-HY-P99781-10MG,MCE-HY-P99781-1MG,MCE-HY-P99781-5MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: MLN-1202

Produktbeschreibung

Plozalizumab (MLN-1202) is a humanized anti-CCR2 IgG1 monoclonal antibody. Plozalizumab blocks the recruitment of myeloid cells to the tumor microenvironment by inhibiting the CCL2/CCR2 axis. In addition, Plozalizumab can also improve synovial inflammation in rheumatoid arthritis. Plozalizumab can be used in the research of malignant melanoma and bone metastasis-related cancers. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001)[1][2][3].

Produkteigenschaften

• Molekulargewicht: (146.08 kDa)
• Reinheit: 99.4
• CAS Nummer: [1610761-46-0]
• Target-Kategorie: CCR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies